BASH-002

About Bash Biotech

Bash Biotech is a private, preclinical-stage biotech based in San Francisco, applying a dual-platform approach of AI/ML and systems biology to decode host-microbiome interactions for therapeutic discovery. The company has a nascent pipeline targeting major unmet needs in chronic kidney disease, kidney cancer, Alzheimer's, and Parkinson's disease, all in preclinical development. Founded with $1M in seed funding, it is pre-revenue and focuses on building its proprietary data platforms (iNetModels, GutMicroNet) to drive its drug repositioning and target identification efforts.

Therapeutic Areas

Other Kidney Cancer Drugs